Showing results (231-240 of 293) with videos related to
Sort By:
Pageof 30
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
An intact canonical NF-κB pathway is required for inflammatory gene expression in response to hypoxiaSusan F Fitzpatrick, Murtaza M Tambuwala, Ulrike Bruning, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancerDavid B Solit, S Percy Ivy, Catherine Kopil, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group studyBrenda J Weigel, Susan M Blaney, Joel M Reid, et al.Journal of the National Cancer Institute|March 31, 2010
Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitorsMichael L Maitland, George L Bakris, Henry R Black, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 14, 2024
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy ParticipantsYingmiao Liu, Jiatong Li, Jing Lyu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancersRamesh K Ramanathan, Merrill J Egorin, Julie L Eiseman, et al.International Journal of Radiation Oncology, Biology, Physics|July 24, 2012
A dose escalation and pharmacodynamic study of triapine and radiation in patients with locally advanced pancreas cancerLudmila Katherine Martin, John Grecula, Guang Jia, et al.Gastroenterology|July 6, 2010
Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier functionMurtaza M Tambuwala, Eoin P Cummins, Colin R Lenihan, et al.Proceedings of the National Academy of Sciences of the United States of America|November 19, 2016
Trypanosoma brucei metabolite indolepyruvate decreases HIF-1α and glycolysis in macrophages as a mechanism of innate immune evasionAnne F McGettrick, Sarah E Corcoran, Paul J G Barry, et al.The Oncologist|June 2, 2019
Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate CancerElisabeth Heath, Lance Heilbrun, Heather Mannuel, et al.Pageof 30